416 related articles for article (PubMed ID: 15567415)
41. Divergent strategy for the synthesis of alpha-aryl-substituted fosmidomycin analogues.
Devreux V; Wiesner J; Jomaa H; Rozenski J; Van der Eycken J; Van Calenbergh S
J Org Chem; 2007 May; 72(10):3783-9. PubMed ID: 17428097
[TBL] [Abstract][Full Text] [Related]
42. Pre-steady-state kinetic analysis of 1-deoxy-D-xylulose-5-phosphate reductoisomerase from Mycobacterium tuberculosis reveals partially rate-limiting product release by parallel pathways.
Liu J; Murkin AS
Biochemistry; 2012 Jul; 51(26):5307-19. PubMed ID: 22690952
[TBL] [Abstract][Full Text] [Related]
43. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
[TBL] [Abstract][Full Text] [Related]
44. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
[TBL] [Abstract][Full Text] [Related]
45. Kinetic and chemical mechanism of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate isomeroreductase.
Argyrou A; Blanchard JS
Biochemistry; 2004 Apr; 43(14):4375-84. PubMed ID: 15065882
[TBL] [Abstract][Full Text] [Related]
46. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
Singh N; Chevé G; Avery MA; McCurdy CR
Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
[TBL] [Abstract][Full Text] [Related]
47. Crystallization and preliminary X-ray crystallographic study of 1-deoxy-D-xylulose 5-phosphate reductoisomerase from Plasmodium falciparum.
Umeda T; Tanaka N; Kusakabe Y; Nakanishi M; Kitade Y; Nakamura KT
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Mar; 66(Pt 3):330-2. PubMed ID: 20208174
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors.
Jackson ER; Dowd CS
Curr Top Med Chem; 2012; 12(7):706-28. PubMed ID: 22283814
[TBL] [Abstract][Full Text] [Related]
49. Mechanistic insights into 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a key enzyme of the MEP terpenoid biosynthetic pathway.
Li H; Tian J; Sun W; Qin W; Gao WY
FEBS J; 2013 Nov; 280(22):5896-905. PubMed ID: 24010408
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of isoprene biosynthesis pathway enzymes by phosphonates, bisphosphonates, and diphosphates.
Cheng F; Oldfield E
J Med Chem; 2004 Oct; 47(21):5149-58. PubMed ID: 15456258
[TBL] [Abstract][Full Text] [Related]
51. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
[TBL] [Abstract][Full Text] [Related]
52. The chemical mechanism of D-1-deoxyxylulose-5-phosphate reductoisomerase from Escherichia coli.
Wong U; Cox RJ
Angew Chem Int Ed Engl; 2007; 46(26):4926-9. PubMed ID: 17516600
[No Abstract] [Full Text] [Related]
53. Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor.
Cobb RE; Bae B; Li Z; DeSieno MA; Nair SK; Zhao H
Chem Commun (Camb); 2015 Feb; 51(13):2526-8. PubMed ID: 25567100
[TBL] [Abstract][Full Text] [Related]
54. Modifications around the hydroxamic acid chelating group of fosmidomycin, an inhibitor of the metalloenzyme 1-deoxyxylulose 5-phosphate reductoisomerase (DXR).
Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
Bioorg Med Chem Lett; 2012 Nov; 22(21):6563-7. PubMed ID: 23025997
[TBL] [Abstract][Full Text] [Related]
55. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
Brücher K; Illarionov B; Held J; Tschan S; Kunfermann A; Pein MK; Bacher A; Gräwert T; Maes L; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2012 Jul; 55(14):6566-75. PubMed ID: 22731758
[TBL] [Abstract][Full Text] [Related]
56. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
[TBL] [Abstract][Full Text] [Related]
57. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
[TBL] [Abstract][Full Text] [Related]
58. Identification of class 2 1-deoxy-D-xylulose 5-phosphate synthase and 1-deoxy-D-xylulose 5-phosphate reductoisomerase genes from Ginkgo biloba and their transcription in embryo culture with respect to ginkgolide biosynthesis.
Kim SM; Kuzuyama T; Chang YJ; Song KS; Kim SU
Planta Med; 2006 Feb; 72(3):234-40. PubMed ID: 16534728
[TBL] [Abstract][Full Text] [Related]
59. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.
Dhiman RK; Schaeffer ML; Bailey AM; Testa CA; Scherman H; Crick DC
J Bacteriol; 2005 Dec; 187(24):8395-402. PubMed ID: 16321944
[TBL] [Abstract][Full Text] [Related]
60. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Tahar R; Basco LK
Am J Trop Med Hyg; 2007 Aug; 77(2):214-20. PubMed ID: 17690389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
